Bullous pemphigoid

Last updated: November 01, 2022

Bullous pemphigoid

MSK Derm

MSK Derm

Skeletal system anatomy and physiology
Muscular system anatomy and physiology
Physiological changes during exercise
Muscle contraction
Muscle weakness: Clinical
Joint pain: Clinical
Non-steroidal anti-inflammatory drugs
Sciatica
Lower back pain: Clinical
Back pain: Pathology review
Gout
Osteoporosis
Systemic lupus erythematosus
Systemic lupus erythematosus (SLE): Clinical
Rheumatoid arthritis
Septic arthritis
Psoriatic arthritis
Reactive arthritis
Seronegative arthritis: Clinical
Rheumatoid arthritis: Clinical
Seronegative and septic arthritis: Pathology review
Rheumatoid arthritis and osteoarthritis: Pathology review
Gout and pseudogout: Pathology review
Antigout medications
Lyme Disease
Borrelia burgdorferi (Lyme disease)
Opioid use disorder
Opioid antagonists
Opioid agonists, mixed agonist-antagonists and partial agonists
Calcium pyrophosphate deposition disease (pseudogout)
Ankylosing spondylitis
Scleroderma
Raynaud phenomenon
Limited systemic sclerosis (CREST syndrome)
Sjogren syndrome
Fibromyalgia
Polymyalgia rheumatica
Dermatomyositis
Polymyositis
Inclusion body myopathy
Osteoarthritis
Baker cyst
Slipped capital femoral epiphysis
Paget disease of bone
Osteomalacia and rickets
Osgood-Schlatter disease (traction apophysitis)
Legg-Calve-Perthes disease
Osteomyelitis
Lordosis, kyphosis, and scoliosis
Radial head subluxation (Nursemaid elbow)
Rotator cuff tear
Meniscus tear
Compartment syndrome
Bone tumors
Developmental dysplasia of the hip
Cleidocranial dysplasia
Achondroplasia
Acetaminophen (Paracetamol)
Osteoporosis medications
Cartilage structure and growth
Bone remodeling and repair
Fibrous, cartilage, and synovial joints
Slow twitch and fast twitch muscle fibers
Sliding filament model of muscle contraction
Neuromuscular junction and motor unit
Atopic dermatitis
Stevens-Johnson syndrome
Erythema multiforme
Psoriasis
Lichen planus
Bullous pemphigoid
Pemphigus vulgaris
Albinism
Vitiligo
Acne vulgaris
Skin cancer
Burns
Skin anatomy and physiology
Hair, skin and nails
Wound healing

Flashcards

Bullous pemphigoid

0 of 11 complete

Questions

USMLE® Step 1 style questions USMLE

0 of 3 complete

Start
A 70-year-old man comes to the office because of severe generalized pruritus and blisters. The pruritus began a month ago, followed by multiple tense blisters over his body two weeks later. Some of the blisters ruptured, causing moist erosions. Past medical history is significant for Parkinson disease and hypertension. Current medications include levodopa/carbidopa and lisinopril. Vitals are within normal limits. Physical examination shows multiple 1 to 3 cm tense bullae as shown:  


Reproduced from Flickr  
Which of the following histological findings will be seen in this patient?  

Transcript

Watch video only

Bullous pemphigoid is an autoimmune skin disease that causes the skin to form bullae or blisters.

Now, the skin is divided into three layers--the epidermis, dermis, and hypodermis.

The epidermis forms the thin outermost layer of skin.

Underneath, is the thicker dermis layer, and finally, there’s the hypodermis that anchors the skin to the underlying muscle.

The epidermis itself is made of multiple layers of developing keratinocytes - which are flat pancake-shaped cells that are named for the keratin protein that they’re filled with.

Keratinocytes start their life at the lowest layer of the epidermis called the stratum basale, or basal layer which is made of a single layer of stem cells, called basal cells that continually divide and produce new keratinocytes.

The stratum basale also contains another group of cells called melanocytes, which secrete melanin.

Melanin is a pigment protein, or coloring substance.

Below the epidermis is the basement membrane which is a thin layer of delicate tissue containing collagen, laminins, and other proteins.

Basal cells are attached to the basement membrane by hemidesmosomes, a protein complex that stems from the bottom of the basal cells.

Just like an anchor digs into the seafloor and holds a boat in place, hemidesmosomes dig into the basement membrane and hold basal cells in place.

The exact cause of bullous pemphigoid is unclear, but it’s thought that in a person with a genetic precondition, it can be triggered by medications like furosemide, captopril, penicillamine, non steroid anti-inflammatory drugs (or NSAIDs), and antibiotics.

Bullous pemphigoid is a type II hypersensitivity reaction, which is when the immune system produces antibodies that bind to the body’s own cells.

Immune cells called B cells produce IgG antibodies, which are Y shaped molecules with 2 regions, an antigen binding fragment region - or Fab region, and fragment crystallizable region or Fc region.

The Fab region of the antibody binds to pathogens which helps other immune cells destroy those pathogens.

The antibodies can also activate a part of the immune system called the complement system, which destroys the pathogen, or induces inflammation.

In bullous pemphigoid, the Fab region of IgG antibodies bind to proteins that make up the hemidesmosome: one of the proteins is called bullous pemphigoid antigen 1 or BPAG1, which is also called dystonin, and another protein is called bullous pemphigoid antigen 2 or BPAG2, which is also called BP 180 or type 17 collagen - lots of names for the same thing.

The Fc region activates the complement system.

The process gets started when C1, the first of the complement proteins, binds the Fc region of the antibody.

C1 then engages other members of the complement family - C2 through C9, some of which are activated by being cleaved or chopped by an enzyme.

Sources

  1. "Robbins Basic Pathology" Elsevier (2017)
  2. "Harrison's Principles of Internal Medicine, Twentieth Edition (Vol.1 & Vol.2)" McGraw-Hill Education / Medical (2018)
  3. "Pathophysiology of Disease: An Introduction to Clinical Medicine 8E" McGraw-Hill Education / Medical (2018)
  4. "CURRENT Medical Diagnosis and Treatment 2020" McGraw-Hill Education / Medical (2019)
  5. "Atypical presentations of bullous pemphigoid: Clinical and immunopathological aspects" Autoimmunity Reviews (2015)
  6. "Assessment of Diagnostic Strategy for Early Recognition of Bullous and Nonbullous Variants of Pemphigoid" JAMA Dermatology (2019)
  7. "Interventions for bullous pemphigoid" Cochrane Database of Systematic Reviews (2010)
  8. "Bullous pemphigoid: Etiology, pathogenesis, and inducing factors: Facts and controversies" Clinics in Dermatology (2013)